Arancio O - Search Results

1

Re-engineering a neuroprotective, clinical drug as a procognitive agent with high in vivo potency and with GABAA potentiating activity for use in dementia.

Luo J, Lee SH, VandeVrede L, Qin Z, Piyankarage S, Tavassoli E, Asghodom RT, Ben Aissa M, Fà M, Arancio O, Yue L, Pepperberg DR, Thatcher GR. Luo J, et al. Among authors: arancio o. BMC Neurosci. 2015 Oct 19;16:67. doi: 10.1186/s12868-015-0208-9. BMC Neurosci. 2015. PMID: 26480871 Free PMC article.

2

Cell cultures from animal models of Alzheimer's disease as a tool for faster screening and testing of drug efficacy.

Trinchese F, Liu S, Ninan I, Puzzo D, Jacob JP, Arancio O. Trinchese F, et al. Among authors: arancio o. J Mol Neurosci. 2004;24(1):15-21. doi: 10.1385/JMN:24:1:015. J Mol Neurosci. 2004. PMID: 15314245

3

Synaptic fatigue is more pronounced in the APP/PS1 transgenic mouse model of Alzheimer's disease.

Zhang H, Gong B, Liu S, Fa' M, Ninan I, Staniszewski A, Arancio O. Zhang H, et al. Among authors: arancio o. Curr Alzheimer Res. 2005 Apr;2(2):137-40. doi: 10.2174/1567205053585936. Curr Alzheimer Res. 2005. PMID: 15974910

4

Amyloid-beta peptide inhibits activation of the nitric oxide/cGMP/cAMP-responsive element-binding protein pathway during hippocampal synaptic plasticity.

Puzzo D, Vitolo O, Trinchese F, Jacob JP, Palmeri A, Arancio O. Puzzo D, et al. Among authors: arancio o. J Neurosci. 2005 Jul 20;25(29):6887-97. doi: 10.1523/JNEUROSCI.5291-04.2005. J Neurosci. 2005. PMID: 16033898 Free PMC article.

5

Alpha-synuclein involvement in hippocampal synaptic plasticity: role of NO, cGMP, cGK and CaMKII.

Liu S, Fa M, Ninan I, Trinchese F, Dauer W, Arancio O. Liu S, et al. Among authors: arancio o. Eur J Neurosci. 2007 Jun;25(12):3583-96. doi: 10.1111/j.1460-9568.2007.05569.x. Eur J Neurosci. 2007. PMID: 17610578

6

Oligomeric amyloid-beta peptide disrupts phosphatidylinositol-4,5-bisphosphate metabolism.

Berman DE, Dall'Armi C, Voronov SV, McIntire LB, Zhang H, Moore AZ, Staniszewski A, Arancio O, Kim TW, Di Paolo G. Berman DE, et al. Among authors: arancio o. Nat Neurosci. 2008 May;11(5):547-54. doi: 10.1038/nn.2100. Epub 2008 Apr 6. Nat Neurosci. 2008. PMID: 18391946 Free PMC article.

7

Inhibition of calpains improves memory and synaptic transmission in a mouse model of Alzheimer disease.

Trinchese F, Fa' M, Liu S, Zhang H, Hidalgo A, Schmidt SD, Yamaguchi H, Yoshii N, Mathews PM, Nixon RA, Arancio O. Trinchese F, et al. Among authors: arancio o. J Clin Invest. 2008 Aug;118(8):2796-807. doi: 10.1172/JCI34254. J Clin Invest. 2008. PMID: 18596919 Free PMC article.

8

Picomolar amyloid-beta positively modulates synaptic plasticity and memory in hippocampus.

Puzzo D, Privitera L, Leznik E, Fà M, Staniszewski A, Palmeri A, Arancio O. Puzzo D, et al. Among authors: arancio o. J Neurosci. 2008 Dec 31;28(53):14537-45. doi: 10.1523/JNEUROSCI.2692-08.2008. J Neurosci. 2008. PMID: 19118188 Free PMC article.

9

Phosphodiesterase 5 inhibition improves synaptic function, memory, and amyloid-beta load in an Alzheimer's disease mouse model.

Puzzo D, Staniszewski A, Deng SX, Privitera L, Leznik E, Liu S, Zhang H, Feng Y, Palmeri A, Landry DW, Arancio O. Puzzo D, et al. Among authors: arancio o. J Neurosci. 2009 Jun 24;29(25):8075-86. doi: 10.1523/JNEUROSCI.0864-09.2009. J Neurosci. 2009. PMID: 19553447 Free PMC article.

10

Dysregulation of histone acetylation in the APP/PS1 mouse model of Alzheimer's disease.

Francis YI, Fà M, Ashraf H, Zhang H, Staniszewski A, Latchman DS, Arancio O. Francis YI, et al. Among authors: arancio o. J Alzheimers Dis. 2009;18(1):131-9. doi: 10.3233/JAD-2009-1134. J Alzheimers Dis. 2009. PMID: 19625751 Free PMC article.

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My Custom Filters

Publication date

Text availability

Article attribute

Article type

Article Language

Species

Sex

Age

Other

211 results

Search Page

Filters